FDA Advisory Committee Recommends TDF/FTC (Truvada) as PrEP for HIV-negative Adults
- Opportunity for public
comment to the FDA is open until May 17 --
details on how to submit are available
here
- Click here to
listen to the recording of a May 15 global
teleconference to discuss the committee's
recommendation and next steps
- Read AVAC's statement on the recommendation for TDF/FTC as PrEP
- For background info,
written statements, media contacts and more
visit www.prepwatch.org
HIV Vaccine Awareness Day 2012
- Register here for an upcoming webinar, HIV Vaccine Awareness Day: Priorities for AIDS vaccine science and advocacy in 2012 and beyond
- Visit the AIDS vaccine page for new resources on the state of the science and advocacy priorities, just in time for HVAD!
Covers the expansion of PxROAR, shines a Spotlight on the Fellows, links to a new cure publication and gives highlights from M2012. Take a look!
WHO issues guidelines on couples HIV testing and counseling (CHTC)
New WHO guidelines recommend offering HIV testing and counseling to couples, wherever HIV testing and counseling is available. Click here for more
HIV risk and hormonal contraceptives
- Visit our page on the subject for background and informational resources
- Listen to a global teleconference discussing WHO recommendations on contraceptive use
- Read a primer on hormonal contraceptives and HIV-1 risk
- New: Survey
on community views of hormonal contraceptive
use and HIV — open through April
30
Spotlight on the Fellows program and PxROAR expands in the US and into Europe
- AVAC releases Spotlight, a biannual update on our Advocacy Fellows program
- PxROAR
gained six new members in the US and expanded
into Europe
The Latest Issue of Px Wire
Featuring a new ARV-based prevention timeline graphic, a description of advocates working to influence PEPFAR Country Operation Plans and more. Read more
AVAC Launches the Research Literacy Database
This is the first central portal for educational resources on biomedical HIV prevention. Take a look
New VMMC Resources: Podcasts, tracking scale-up and more
To mark the five-year anniversary of VMMC being recognized as a highly effective HIV prevention strategy, AVAC is launching an expanded set of resources seeking to inform, analyze and accelerate progress on VMMC rollout. Click for more
GPP Tools: Getting the guidelines off the shelf and into practice
Explore new sets of tools that will help research teams and other stakeholders understand, implement and monitor the Good Participatory Practice (GPP) Guidelines for biomedical HIV prevention trials
Advocacy in the FDA review of Truvada as PrEP
The FDA decision on PrEP will be made within six months. More information on how advocates can be a part of the process is available:
- Read An Advocate's Primer for Public Participation
- Listen to the webinar, Navigating the FDA Review Process
- Details
on submitting
comments directly to the FDA are
available